Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …

Adult and paediatric patients with pathogenic variants in the gene encoding succinate
dehydrogenase (SDH) subunit B (SDHB) often have locally aggressive, recurrent or …

Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …

A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …

Imaging plays a critical role in the management of pheochromocytomas and
paragangliomas and often guides treatment. The discovery of susceptibility genes …

Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and
parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal …

Purpose: Patients with succinate dehydrogenase subunit B (SDHB) mutation–related
pheochromocytoma/paraganglioma (PHEO/PGL) are at a higher risk for metastatic disease …

BACKGROUND: There are currently no reliable biomarkers for malignant
pheochromocytomas and paragangliomas (PPGLs). This study examined whether …

Two different primary malignancies can arise from the adrenal gland: the adrenocortical
carcinoma (ACC) from the adrenal cortex and the malignant pheochromocytoma from the …